Pharmacy and Drug Information
Pharmacy Updates
11/2023 – Opioid Strategy Prescriber Notification 2024
05/2023 – Notice of Changes to the Formulary effective 7/01/2023 (addition of PA to Ozempic)
12/2022 – Information on Biosimilars
Biosimilars: Are They the Same Quality?
Biosimilars & Interchangeable Products: Free Continuing Education Courses from FDA
- Biosimilars 101: A Primer for Your Practice
- Test Your Skill: Incorporating Biosimilars Into the Management of Patients with Immunological Conditions
- Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care
- Putting the Patient into Perspective: Strategies for Educating Patients About Biosimilars
11/2022 – 2023 Provider Information of Opioid Drug Management Program (DMP).
08/2022 – Addition of TRIZIVIR 150-300 MG TABLET to the Formulary
06/2022 – Information on Biosimilars
Reference: Overview of Biosimilar Products
For more information, visit:
- Biosimilars: Health Care Provider Materials
- Prescribing Biosimilar and Interchangeable Products
- Biosimilar and Interchangeable Biologics: More Treatment Choices
03/01/2022 – Notice of Changes to the Formulary effective 4/01/2022.
12/2021 – 2022 Provider Information of Opioid Drug Management Program (DMP).
08/2021 – Notice of Changes to the Formulary.
01/2021 – 2021 Provider Notification of Opioid Drug Management Program.
12/2020 – Warning on Concurrent use of Opioids and Benzodiazepines.
11/2020 – 2021 Formulary Update.
02/2020 – Newsletter – Provider Formulary Updates.
11/2019 – 2020 Provider Notification of Opioid Drug Management Program (DMP).
11/2019 – HHS Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use.
07/2019 – Newsletter – Provider Formulary Updates.
12/2018 – 2019 Provider notification of Opioid Drug Management Program.
Provider Prevention of Unauthorized Prescribing
To learn more click below:
- CMS: Partners in Integrity-What Is a Prescriber’s Role in Preventing the Diversion of Prescription Drugs https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/provider-education-toolkits/downloads/prescriber-role-drugdiversion.pdf
- E-FORCSE®, Florida’s Prescription Drug Monitoring Program Home Page http://www.floridahealth.gov/statistics-and-data/e-forcse/
Influenza Season 2023-2024 Update
Recalls and Drug Safety Communications
03/2024 – Recall Notice: Treprostinil Injection 20mg/20mL (1mg/mL) from Par Pharmaceuticals
11/2023 – FDA Drug Safety Communication: Levetiracetam and Clobazam 11.28.23
11/2023 – Recall Notice: Vitrakvi (larotrectinib) Oral Solution 20 mg/mL from Bayer_11.22.23
10/2023 – Recall Notice: Betaxolol 10 mg tablets by KVK-Tech, Inc._10.03.23
09/2023 – Recall Notice: Brexafemme 150 mg tablets by Scynexis, Inc._ 9.28.23
09/2023 – Recall Notice: Sucralfate Oral Suspension 1g-10mL by VistaPharm_RECALL 9.22.23
09/2023 – Recall Notice: Digoxin Tablets 0.125mg and Digoxin Tablets 0.25mg Due to Label Mix-Up
05/2023 – Recall Notice: Akorn All-Products Recall Due to Company Shutdown
04/2023 – Recall Notice: Atovaquone Oral Suspension, USP 750mg/5mL by Camber Pharmaceuticals
03/2023 – Recall Notice: Dabigatran Etexilate Capsules, USP 75 mg and 150 mg by Ascend Laboratories
01/2023 – Recall Notice: Quinapril tablets by Lupin Pharmaceuticals
10/2022 – Drug Recall Notice Quinapril-HCTZ 20mg/12.5mg tablets by Aurobindo
06/2022 – Drug Withdrawal from Market Notice- Ukoniq 200 mg tablets
05/2022 – Drug Recall Notice Anagrelide Capsules, USP 0.5 mg by Teva
04/2022 – Drug Recall Notice Accupril 10mg, 20mg, 40 mg tabs by Pfizer
03/2022 – Drug Recall Notice Orphenadrine ER 100 mg tab by Sandoz Pharmaceuticals
01/2022 – Metformin 750 mg ER tab by Viona Pharmaceuticals
12/2021 – Enoxaparin Sodium 40mg/0.4 mL injection by Sandoz
11/2021 – Lupin Pharmaceuticals’ Irbesartan and Irbesartan-HCTZ tablets
11/2021 – Drug Recall Notice for one lot of GLUCAGON® Emergency Kit
10/2021 – Drug Recall Notice Chantix tablets- All lots.
08/2021 – Drug Recall Notice Chantix tablets.
07/2021 – Drug Recall Notice Metformin HCl Extended-Release Tablets, USP 750 mg.
05/2021 – Drug Recall Notice NP Thyroid tablets.
02/2021 – FDA Drug Safety Communication: Xeljanz, Xeljanz XR.
02/2021 – Drug Recall Notice Enoxaparin Sodium Inj. by Apotex.
07/2020 – Drug Recall Notice Granule Pharmaceuticals Metformin Hydrochloride ER 750 mg tablets.
06/2020 – Drug Recall Notice Teva Metformin Hydrochloride ER 500 mg and 750 mg tablets.
06/2020 – Drug Recall Notice Amneal Metformin Hydrochloride ER 500 mg and 750 mg tablets.
05/2020 – Drug Recall Notice NP Thyroid tablets.
04/2020 – Drug Recall Notice Tetracycline 250mg and 500mg capsules.
04/2020 – Drug Recall Notice ALL Ranitidine and ZANTAC products.
01/2020 – Drug Recall Notice Ranitidine 150mg and 300mg capsules (Appco)
01/2020 – Drug Recall Notice Aurobindo Mirtazapine 7.5 mg tablets lot #03119002A3
12/2019 – Drug Recall Notice Expansion Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup
11/2019 – Drug Recall Notice Amneal Ranitidine 150mg and 300mg Tablets and 15mg/mL syrup
11/2019 – Drug Recall Notice Novitium Ranitidine 150 mg and 300 mg tablets
11/2019 – Drug Recall Notice Lannett Ranitidine 15mg/mL syrup
10/2019 – Drug Recall Notice Mylan Alprazolam products
10/2019 – Drug Recall Notice Dr. Reddy’s Ranitidine products
10/2019 – Drug Recall Notice Sandoz Rantidine Capsules
10/2019 – FDA Drug Safety Communication – Zantac (Ranitidine)
09/2019 – Drug Recall Notice – NATPARA (Parathyroid Hormone) for Injection
09/2019 – FDA Drug Safety Communication: Xeljanz, Zeljanz XR
08/2019 – Over the Counter (OTC) recall of multiple Altaire Ophthalmic products at CVS
08/2019 – Drug Recall Notice Relpax 40 mg tablets
07/2019 – Drug Recall – Altaire Pharmaceuticals – Ophthalmics
05/2019 – Drug Recall Notice Losartan and Losartan HCTZ
05/2019 – Drug Recall Losartan
05/2019 – FDA Drug Safety Communication for Prescription Insomnia Medicines: New Boxed Warning – Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake
04/2019 – Drug Recall Notice – Losartan Legacy MFXR
04/2019 – Drug Recall Notice – Valsartan
04/2019 – Drug Recall Notice Losartan and Losartan HCTZ
04/2019 – Drug Recall Notice Losartan
04/2019 – Drug Recall Notice Losartan HCTZ
01/2019 – Drug News and Alerts/ Recall Notice for Irbesartan and Irbesartan HCTZ Tablets.
01/2019 – Drug News and Alerts/Recall Notice for Losartan Potassium tablets.
H4140_PRWSNOTIF_C
Last Updated: 04/23/2024
